Device Trial Radar · NCT06748885
Mpact 3D Metal Monolit Study
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
88
Planned (sponsor's estimate)
Start
Feb 28, 2024
Primary completion
Dec 2030
Study completion Dec 2030
Sponsor
- Lead sponsor
- Medacta International SANot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 27, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life. Surgeons are constantly seeking to improve all aspects of care related to this procedure, whether it be improving implant technology, improving instrumentation or the technique involved in performing the procedure. In recent years, a new porous titanium coating has been introduced to promote good osseointegration of uncemented cups. High friction torque and a feeling of immediate anchorage provide excellent primary stability, while high porosity ensures bone growth providing secondary stability. With higher porosity than standard coatings, a greater volume of bone can be present in the porous surface, giving a proportional increase in force at the interface. he Mpact 3D Metal Monolith cup has been designed to provide greater range of motion and improved joint stability, with a reduced risk of dislocation. It is an innovative design that improves stability and provides a favourable environment for long-term biological metal-bone fixation. The current study aims to collect clinical and radiological data to assess the function of the operated hip and the stability of the Mpact 3D Metal Monolith cup at 2 years and survival at 5 years for the treatment of patients requiring hip arthroplasty.
Conditions
- Total Hip Arthroplasty (THA)
Interventions
Mpact 3D Metal MonolithDevice
THA with Mpact 3D Metal Monolith
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of the hip functionTime frame: Preoperative, 3 months, 6 months, 1 year, 2 years, 5 years
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Clinique Brétéché
Nantes, France · Not yet recruiting
Hôpital Lariboisière
Paris, France · Not yet recruiting
Hôpital Cochin
Paris, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.